T2	Anatomical_entity 507 511	BALF
T5	Organic_compound_other 837 840	LPS
T7	Disorder 691 694	IPF
T8	Disorder 1395 1398	IPF
T9	Cell 858 863	cells
T10	Cell 909 929	alveolar macrophages
T11	Anatomical_entity 966 970	BALF
T12	Entity_Property 1007 1020	chronic phase
T13	Cell 11 31	alveolar macrophages
T15	Anatomical_entity 265 269	BALF
T16	Subject 677 685	patients
T19	Cell 931 933	AM
T20	Disorder 599 602	SAR
T21	Disorder 1343 1353	alveolitis
T22	Disorder 416 427	sarcoidosis
T23	GGPs 143 156	interleukin-8
T27	Cell 971 976	cells
T29	Disorder 78 107	idiopathic pulmonary fibrosis
T31	Anatomical_entity 669 673	BALF
T32	Subject 336 349	five patients
T34	GGPs 469 473	IL-8
T38	Subject 396 410	eight patients
T39	Disorder 429 432	SAR
T41	Cell 1075 1079	cell
T44	GGPs 158 162	IL-8
T45	Subject 603 611	patients
T46	Negation_cue 486 489	not
T49	Entity_Property 1377 1391	subacute phase
T50	Subject 274 288	eight patients
T51	Cell_component 775 788	extracellular
T52	Disorder 533 536	IPF
T53	Subject 1239 1247	patients
T54	Cell_component 1031 1044	extracellular
T57	Subject 982 990	patients
T58	Anatomical_entity 235 263	bronchoalveolar lavage fluid
T60	Organic_compound_other 946 949	LPS
T61	Disorder 218 221	IPF
T62	Disorder 187 216	idiopathic pulmonary fibrosis
T63	Organic_compound_other 817 835	lipopolysaccharide
T64	Cellular_process 1330 1342	neutrophilic
T65	Subject 64 72	patients
T67	Anatomical_entity 853 857	BALF
T68	Disorder 355 358	IPF
T69	Entity_Property 544 557	chronic phase
T70	Cell 793 797	cell
T72	Cell 1099 1101	AM
T73	Cell 1233 1235	AM
T74	Disorder 294 297	IPF
T75	Disorder 1253 1256	IPF
T76	Subject 519 527	patients
T77	Disorder 996 999	IPF
E1	Cellular_process:T64 
N3	Reference T2 UMLS:C0006279	Bronchoalveolar Lavage Fluid
N10	Reference T5 UMLS:C0023810	Lipopolysaccharides
N22	Reference T7 UMLS:C1800706	Idiopathic Pulmonary Fibrosis
N25	Reference T8 UMLS:C1800706	Idiopathic Pulmonary Fibrosis
N30	Reference T9 UMLS:C0007634	Cells
N31	Reference T10 UMLS:C0085236	Macrophages, Alveolar
N33	Reference T11 UMLS:C0006279	Bronchoalveolar Lavage Fluid
N36	Reference T12 UMLS:C0457343	Chronic phase
N37	Reference T13 UMLS:C0085236	Macrophages, Alveolar
N43	Reference T15 UMLS:C0006279	Bronchoalveolar Lavage Fluid
N45	Reference T16 UMLS:C0030705	Patients
N58	Reference T19 UMLS:C0085236	Macrophages, Alveolar
N63	Reference T21 UMLS:C0549493	Alveolitis
N66	Reference T22 UMLS:C0036202	Sarcoidosis
N72	Reference T23 UMLS:C0079633	Interleukin-8
N90	Reference T27 UMLS:C0007634	Cells
N93	Reference T29 UMLS:C1800706	Idiopathic Pulmonary Fibrosis
N98	Reference T31 UMLS:C0006279	Bronchoalveolar Lavage Fluid
N100	Reference T32 UMLS:C0030705	Patients
N120	Reference T38 UMLS:C0030705	Patients
N129	Reference T41 UMLS:C0007634	Cells
N141	Reference T45 UMLS:C0030705	Patients
N152	Reference T49 UMLS:C0205365	Subacute
N153	Reference T50 UMLS:C0030705	Patients
N156	Reference T51 UMLS:C0521119	Extracellular
N157	Reference T52 UMLS:C1800706	Idiopathic Pulmonary Fibrosis
N160	Reference T53 UMLS:C0030705	Patients
N163	Reference T54 UMLS:C0521119	Extracellular
N168	Reference T57 UMLS:C0030705	Patients
N170	Reference T58 UMLS:C0006279	Bronchoalveolar Lavage Fluid
N176	Reference T60 UMLS:C0023810	Lipopolysaccharides
N181	Reference T61 UMLS:C1800706	Idiopathic Pulmonary Fibrosis
N183	Reference T62 UMLS:C1800706	Idiopathic Pulmonary Fibrosis
N187	Reference T63 UMLS:C0023810	Lipopolysaccharides
N189	Reference E1 UMLS:C0746885	neutrophilic
N190	Reference T65 UMLS:C0030705	Patients
N196	Reference T67 UMLS:C0006279	Bronchoalveolar Lavage Fluid
N198	Reference T68 UMLS:C1800706	Idiopathic Pulmonary Fibrosis
N202	Reference T69 UMLS:C0457343	Chronic phase
N206	Reference T70 UMLS:C0007634	Cells
N215	Reference T72 UMLS:C0085236	Macrophages, Alveolar
N217	Reference T73 UMLS:C0085236	Macrophages, Alveolar
N220	Reference T74 UMLS:C1800706	Idiopathic Pulmonary Fibrosis
N222	Reference T75 UMLS:C1800706	Idiopathic Pulmonary Fibrosis
N225	Reference T76 UMLS:C0030705	Patients
N227	Reference T77 UMLS:C1800706	Idiopathic Pulmonary Fibrosis
N2	Reference T39 UMLS:C0036202	Sarcoidosis
N4	Reference T20 UMLS:C0036202	Sarcoidosis
N6	Reference T44 UMLS:C0079633	Interleukin-8
N8	Reference T34 UMLS:C0079633	Interleukin-8
T30	GGPs 809 813	IL-8
N9	Reference T30 UMLS:C0079633	Interleukin-8
T78	GGPs 1045 1049	IL-8
N13	Reference T78 UMLS:C0079633	Interleukin-8
T79	GGPs 881 885	IL-8
N14	Reference T79 UMLS:C0079633	Interleukin-8
T80	GGPs 1091 1095	IL-8
N17	Reference T80 UMLS:C0079633	Interleukin-8
T81	GGPs 1272 1276	IL-8
N19	Reference T81 UMLS:C0079633	Interleukin-8
T82	GGPs 1306 1310	IL-8
N20	Reference T82 UMLS:C0079633	Interleukin-8
T83	GGPs 36 49	interleukin-8
N23	Reference T83 UMLS:C0079633	Interleukin-8
T84	Subject 439 467	eight control (CTL) subjects
T86	Subject 1148 1160	CTL subjects
N15	Reference T86 UMLS:C0009932	Control Groups
N11	Reference T84 UMLS:C0009932	Control Groups
T18	Entity_Property 305 334	chronically progressive phase
T26	Entity_Property 366 394	subacutely progressive phase
R1	Subject_Disorder Arg1:T65 Arg2:T29	
R2	Subject_Disorder Arg1:T50 Arg2:T74	
R3	Subject_Disorder Arg1:T32 Arg2:T68	
R4	Subject_Disorder Arg1:T38 Arg2:T22	
R5	Subject_Disorder Arg1:T76 Arg2:T40	
R6	Subject_Disorder Arg1:T16 Arg2:T7	
R7	Subject_Disorder Arg1:T45 Arg2:T20	
R8	Subject_Disorder Arg1:T57 Arg2:T48	
R9	Subject_Disorder Arg1:T53 Arg2:T75	
T3	Gene_expression 474 480	levels
E3	Gene_expression:T3 Theme:T34 atLoc:T2
N5	Reference E3 UMLS:C1519614	Genetic Translation Process
T43	Gene_expression 886 895	producing
E4	Gene_expression:T43 Theme:T79 atLoc:T10 Cue:T92
N12	Reference E4 UMLS:C1519614	Genetic Translation Process
T85	Gene_expression 1277 1287	production
E5	Gene_expression:T85 Theme:T81 atLoc:T73
N16	Reference E5 UMLS:C1519614	Genetic Translation Process
T56	Gene_expression 50 60	production
E6	Gene_expression:T56 Theme:T83 atLoc:T13
N21	Reference E6 UMLS:C1519614	Genetic Translation Process
T87	Positive_regulation 652 661	increased
E8	Positive_regulation:T87 atLoc:T31
N24	Reference E8 UMLS:C1879547	Activation action
T88	Positive_regulation 1107 1116	increased
E9	Positive_regulation:T88 Theme:T80 atLoc:T72
N26	Reference E9 UMLS:C1879547	Activation action
T89	Positive_regulation 490 499	increased
E10	Positive_regulation:T89 Cue:T46 Theme:E3
N27	Reference E10 UMLS:C1879547	Activation action
T90	Positive_regulation 842 852	stimulated
E11	Positive_regulation:T90 Cause:T63 Theme:T9
N28	Reference E11 UMLS:C1879547	Activation action
T91	Positive_regulation 950 961	stimulation
E12	Positive_regulation:T91 Cause:T60 Theme:T27
N29	Reference E12 UMLS:C1879547	Activation action
T71	Biological_process 171 183	pathogenesis
E2	Biological_process:T71 Theme:T62
N32	Reference E2 UMLS:C0699748	Pathogenesis
E13	Positive_regulation:T88 Theme:T78
N34	Reference E13 UMLS:C1879547	Activation action
T47	Correlation 1315 1326	play a role
E14	Correlation:T47 Theme:T21 Theme2:T82 Cue:T94 Cue2:T95
T14	Positive_regulation 127 139	contribution
E15	Positive_regulation:T14 Cause:T23 Theme:E2 Cue:T37 Cue2:T66
N38	Reference E15 UMLS:C1879547	Activation action
A1	Negated E10
T17	Localization 798 808	associated
E16	Localization:T17 Theme:T30 atLoc:T70
N39	Reference E16 UMLS:C0450429	Location
T28	Localization 1080 1090	associated
E17	Localization:T28 Theme:T80 atLoc:T41
N40	Reference E17 UMLS:C0450429	Location
R16	part_of Arg1:T31 Arg2:T16	
T25	Entity_Property 702 730	subacutely progressive phase
R17	part_of Arg1:T27 Arg2:T11	
N7	Reference E14 UMLS:C0332281	Associated with
T4	Positive_regulation 1261 1267	primed
E7	Positive_regulation:T4 Theme:T73 Cue:T93 disorder:T75
N35	Reference E7 UMLS:C1879547	Activation action
T35	Positive_regulation 0 7	Priming
E18	Positive_regulation:T35 Theme:T13 disorder:T29
N42	Reference E18 UMLS:C1879547	Activation action
T36	Pharmacological_substance 1053 1066	culture fluid
N44	Reference T36 UMLS:C0010454	Culture Media
T37	Speculation_cue 113 122	evaluated
T6	Disorder 294 334	IPF in the chronically progressive phase
N18	Reference T6 UMLS:C1800706	Idiopathic Pulmonary Fibrosis
T33	Disorder 355 394	IPF in the subacutely progressive phase
N41	Reference T33 UMLS:C1800706	Idiopathic Pulmonary Fibrosis
T40	Disorder 533 557	IPF in the chronic phase
N47	Reference T40 UMLS:C1800706	Idiopathic Pulmonary Fibrosis
T42	Disorder 691 730	IPF in the subacutely progressive phase
N48	Reference T42 UMLS:C1800706	Idiopathic Pulmonary Fibrosis
T48	Disorder 996 1020	IPF in the chronic phase
N49	Reference T48 UMLS:C1800706	Idiopathic Pulmonary Fibrosis
R20	member_of Arg1:T40 Arg2:T52	
R21	member_of Arg1:T48 Arg2:T77	
T59	Disorder 1377 1398	subacute phase of IPF
N50	Reference T59 UMLS:C1800706	Idiopathic Pulmonary Fibrosis
R22	member_of Arg1:T59 Arg2:T8	
N51	Reference T18 UMLS:C0457343	Chronic phase
N52	Reference T25 UMLS:C0205365	Subacute
N53	Reference T26 UMLS:C0205365	Subacute
R23	member_of Arg1:T6 Arg2:T74	
R24	member_of Arg1:T33 Arg2:T68	
R25	member_of Arg1:T42 Arg2:T7	
R26	part_of Arg1:T2 Arg2:T76	
E20	Positive_regulation:T89 
A2	Negated E20
N55	Reference E20 UMLS:C1879547	Activation action
A3	Speculated E15
T66	Speculation_cue 226 234	studying
T92	Speculation_cue 867 876	determine
A4	Speculated E4
T93	Speculation_cue 1220 1227	suggest
T94	Speculation_cue 1292 1300	conclude
T95	Speculation_cue 1311 1314	may
A5	Speculated E14
R18	part_of Arg1:T9 Arg2:T67	
